E9. Side-effects of tamoxifen and solutions with aromatase inhibitors

European Journal of Cancer, Supplement

Volumn 2, Issue 9 SPEC. ISS., 2004, Pages 33-34

  Cuzick, Jack ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; BISPHOSPHONIC ACID DERIVATIVE; RISEDRONIC ACID; TAMOXIFEN;

BONE DEMINERALIZATION; BREAST CANCER; CANCER PREVENTION; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; ENDOMETRIAL DISEASE; ENDOMETRIUM CANCER; FRACTURE; HOT FLUSH; HUMAN; MUSCULOSKELETAL DISEASE; PRIORITY JOURNAL; STROKE; THROMBOEMBOLISM; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; VAGINA BLEEDING;

EID: 9744241814     PISSN: 13596349     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcsup.2004.08.009     Document Type: Conference Paper

References (6)

1. Early Breast Cancer Trialists Collaborative Group. Favourable and unfavourable effects of long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2000, 355, 1757-1770.
2. Cuzick J. A brief review of the International Breast Cancer Intervention Study (IBIS), the other current breast cancer prevention trials, and proposals for future trials. In: Marietta Anthony, Barbara K. Dunn, Sherry Sherman (editors). Selective estrogen receptor modulators [SERMs], Ann NY Acad Sci 2002, 949, 123-133.
3. Cuzick J, Powles T, Veronesi U, et al. Overview of the main outcomes in breast cancer prevention trials. Lancet 2003, 361, 296-300.
4. The ATAC Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 2002, 359, 2131-2139.
5. The ATAC Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer - Results of the ATAC (arimidex, tamoxifen alone or combination) trial efficacy and safety update analysis. Cancer 2003, 98, 1802-1810.
6. Fisher B, Costantino JP, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998, 90, 1371-1388.